About
Professor Glen Boyle is Head of the Cancer Drug Mechanisms Group in the Cancer Program at QIMR Berghofer. Professor Boyle established his group in October 2013 and was promoted to Senior Research Fellow in February 2015. He was the recipient of the Wilson Fellowship for Skin Cancer Research sponsored by Perpetual Trustees (2013-2016). He has been a Smart Futures Researcher-in-Residence sponsored by the Queensland Government (2011-2012) and has held National Health and Medical Research Council (NHMRC) and Cancer Council Queensland Grants investigating novel pathways in the formation of skin cancer and melanoma and the development of novel anti-cancer treatments. Professor Boyle has been investigating the molecular development of head and neck and cutaneous squamous cell carcinoma and melanoma since 1999. Professor Boyle holds adjunct positions at the University of Queensland and Queensland University of Technology.
Research Skills
Molecular Biology, Drug Discovery, Drug Development, Models of Metastasis, Models of Cancer Therapy Resistance
Area of Interest
Melanoma, Head and Neck Cancer, Skin Cancer, Pancreatic Cancer, Sarcoma, Cancer Heterogeneity